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Abstract: Thyroid hormones are involved in the development of several tissues and organs and are essential 
for the normal growth and reproductive function. The aim of this study was to determine the effects of thyroid 
hormones on the development of testis and progression of spermatogenesis. Lactating mothers were treated with 
oral thyroxine (T4; 20 µg/100 g) for 20 days after parturition. The pups were decapitated at the age of 20, 40 and 
60 days post partum. Neonatal hyperthyroidism resulted in a decrease in body and testis mass, an increase of free 
thyroxine and a decrease of testosterone concentrations in plasma of treated rats. The treatment was associated 
with a significant decrease of the diameter of seminiferous tubules and a slowdown in spermatogenesis, following 
a delay in the maturation of germ cells. We conclude that thyroid hormones affect the progression of postnatal 
spermatogenesis. (Folia Histochemica et Cytobiologica 2013, Vol. 51, No. 2, 107–114)
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Sertoli cells to nurture germ cells [6]. Consequences 
of thyroidectomy on hormonal levels, including 
a reduction of GH and FSH blood levels have also 
been reported [6]. Conversely, short period of neo-
natal hyperthyroidism is associated with an increase 
in the size of testis and both Sertoli and germ cells 
number, reduced TSH levels, and a slight increase 
of blood FSH concentration [7, 8]. It seems that 
elevation of TH levels induces hypotrophy of fetal 
Leydig cells, and causes early differentiation of an 
increased number of mesenchymal cells into adult 
Leydig cells in prepubertal rats [9]. Although many 
reports demonstrating the effects of TH deficiency 
or excess on testicular function are available in lite-
rature [10, 11], little is known about the effects of 
an elevation of blood TH levels in lactating mothers 
on the maturation of male gonads in their offspring. 
This led us to investigate the effects of hyperthyroxi-
nemia on the evolution of male gonadic function 
across different ages.
Material and methods
Animals. Female Wistar rats (n = 14) were housed under 
conditions of controlled lighting (light on from 8:00 AM 
to 6:00 PM) and temperature (25 ± 2°C) and fed with 
Introduction 
Among hormones secreted by the thyroid gland, 
thyroxine (T4) is the most abundant form, conver-
ted to the active hormone triiodothyronine (T3) by 
deiodinase enzymes (D1, D2 and D3). Several studies 
have demonstrated the effects of thyroid hormones 
(TH) on male gonads. It has been reported that hy-
pothyroidism prolongs the proliferative phase of Ser-
toli cells and inhibits their differentiation, leading to 
a higher number of Sertoli cells, and in consequence 
to an increase in testicular size and sperm count at 
adulthood [1–4]. Treatment with propylthiouracil 
(PTU), an antithyroid drug, induced a maturation 
arrest of spermatogenesis, reduced the number of 
Leydig cells, decreased tubular diameter, caused 
interstitial edema and thickening of the basement 
membrane [5]. Thyroidectomy caused a reduction in 
the diameter of seminiferous tubules and their lumen, 
and led to degenerative changes in spermatogenic 
cells, which could have resulted from the inability of 
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commercial chow (23.3% proteins, 9% lipids, 48% car-
bohydrates and 3% vitamin mineral complex) ad libitum. 
After mating, each female was placed in an individual cage 
with free access to water and food. After birth, the dams 
with their respective pups were divided in two groups 
of 7 lactating mothers each one. The treated group (T) 
of lactating dams (kept with their pups) received a dose 
of 20 mg/100g body weight (BW) of thyroxine (sodium 
salt of levothyrox ‘H03AA01’ solution, SERB, Paris, France) in 
drinking water, for 20 days starting first day post partum (dpp), 
whereas the control group (C) of neonatal rats was kept with 
their dams which received tap water. The pups were followed 
up and weighted weekly until their sacrifice at the ages of 20, 
40 and 60 dpp. The pups were weaned at 30 dpp.
Hormone assays. Blood was collected from treated and 
control decapitated rats. Plasma was separated and kept 
at –20°C until analyses. Plasma free thyroxin (FT4) and 
testosterone levels were measured in duplicate using the 
radio-immunoassay (RIA) method (IM1363 and IM1119 
for thyroxin and testosterone, respectively; Immunotech 
SAS, Marseille, France).
Histological and morphometric analyses. The testes were 
fixed in Bouin-Hollande solution for 3 days and embedded 
in paraffin prior to histological and morphometric studies 
of seminiferous tubules. Five micrometers thick sections 
were stained by Masson’s trichrome method. The slides were 
viewed and photographed using a Zeiss photomicroscope 
equipped with a Motic digital camera and an ocular grid. 
The average tubular and luminal diameters of seminiferous 
tubules were determined by measuring 45 randomly selected 
tubular cross-sections per group and age.
Statistical analysis. Data are expressed as mean ± standard 
error of the mean (SEM). Groups were compared using 
Student’s t-test, and values of p < 0.05 were considered to 
be significantly different. Body and testis weights and tubular 
and luminal diameters were assumed to be normally distri-
buted. To obtain a normal distribution, plasma hormone 
levels were transformed to logarithms.
Results 
Body mass
At 7 dpp, the average body weights of the two groups 
of pups were similar. From 14 dpp, the body weight was 
significantly lower in pups which mothers were treated 
with thyroxine (experimental group) compared with age 
matched control groups until 35 dpp (60.42 ± 0.88 g vs. 
73.69 ± 2.93 g; p < 0.001). Later, the body weight values 
were higher in treated groups, however, not significantly 
different from the control rats (Figure 1).
Testis mass 
No difference was observed between the weight of 
the left testis and the right testis indicating absence 
of testicular dimorphism. During maturation (20 to 
60 dpp), the testicular weight of control and treated 
rats increased gradually. At the age of 20 and 40 days, 
the mean testes weights of treated animals were lower 
than in control rats. Only right testes of 20-day-old 
treated group weighed significantly less than those of 
the control (88.78 ± 8.79 mg vs. 138.40 ± 18.47 mg; p 
< 0.05). At 60 dpp, mean testes weights of treated rats 
were higher than those of control rats, however, the 
differences were not statistically significant (Figure 2).
Figure 2. Testis mass in control (C) and postnatal thyroxine 
treated (T) rats at 20, 40 or 60 days post partum (dpp). Bars 
represent mean ± SEM; treated vs. control: *p < 0.05; R 
— Right testis, L — Left testis; n ≥ 5
Figure 1. Body mass in control (C) and postnatal thyroxine 
treated (T) rats. Bars represent mean ± SEM; treated vs. 
control: **p < 0.01, ***p < 0.001; n ≥ 9
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Plasma hormone concentrations
FT4 levels of control rats increased gradually in an 
age-dependent manner while FT4 levels of the treated 
group increased during 20 days of dams’ T4 treatment, 
were reduced 20 days later and increased again at 
60 dpp. Plasma FT4 concentration on 20th day in the 
treatment group was higher by 47.81% when compa-
red with the mean value obtained in control group 
(22.32 ± 2.64 pM vs. 15.10 ± 1.12 pM, respectively; 
p < 0.05). At 40 days FT4 levels were similar in both 
groups, and at 60 days, FT4 concentration was lower 
by 16.92% in treated than in control rats (not signifi-
cant different) (Figure 3). 
In control rats plasma testosterone levels increased 
gradually with age while in treated animals testoste-
rone concentration increased slightly after 40 dpp, yet 
remained lower than in controls. The level of testo-
sterone was lower in treated than in control animals 
by 49.09%, 36.36% and 51.88% at 20, 40 and 60 dpp, 
respectively, though at 60 dpp the difference did not 
reach statistical significance (Figure 4). 
Morphometric analysis
The morphometric evaluation of testis structure 
revealed a reduced diameter of seminiferous tubules 
in treated 20-day-old rats as compared with control 
animals (189.5 ± 2.67µm vs. 220.69 ± 3.13µm, respec-
tively, p < 0.001) (Figure 5). In the treated 20-day-old 
rats, the lumen was reduced by 22.54%, (p < 0.05 vs. 
control) in some tubules and closed in others. The 
mean diameter of tubules of 40-day-old treated rats 
compared to control group was lower, and the mean 
diameter of tubule’s lumen did not differ between 
treated and control groups. At 60 dpp the diameter of 
seminiferous tubules was higher by 6.19% and lumen 
diameter was higher by 14.82% in the treated group 
than in the control (Table 1).
Testis morphology
At the age of 20 days, spermatogonia and sperma-
tocytes I were observed in the basal and adluminal 
areas, respectively, in control animals’ testes. In tre-
ated rats, spermatogonia were frequently displaced 
from the basal area in those tubules which presented 
a lumen, while spermatocytes were condensed in the 
center of the tubules without well-defined lumen (a1, 
b1; Figure 5). Spermatogenesis appeared to be slower 
in treated animals at 40 dpp. The most advanced type 
of germ cell was spermatocyte II in treated animals, 
while the tubules of control animals contained some 
spermatozoa. These differences were absent in te-
stes sections of 60-day-old rats since all the tubules 
contained spermatozoa, however, the seminiferous 
epithelium showed impaired germ cell development 
in T4 treated animals (e1, f1; Figure 6).
Discussion
In this study, 20-day-old rats, breast-fed by lactating 
females who received Levothyrox, were hyperthyro-
id as compared to age-matched control pups. The 
increased FT4 level of the treated rats suggests that 
thyroid hormones were transferred to the pups with 
Figure 3. Plasma thyroxine concentrations in control (C) 
and postnatal thyroxine treated (T) rats at 20, 40 or 60 
days post partum (dpp). Bars represent mean ± SEM; 
treated vs. control: *p < 0.05; n ≥ 5 
Figure 4. Plasma testosterone concentrations in control 
(C) and postnatal thyroxine treated (T) rats at 20, 40 or 
60 days post partum (dpp). Bars represent mean ± SEM; 
treated vs. control: *p < 0.05; n ≥ 5
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Table 1. Diameters of the seminiferous tubule lumen in control (C) and postnatal thyroxine treated (T) rats at 20, 40 or 
60 days post partum (dpp)
20 dpp 40 dpp 60 dpp
Diameter (mm)
Tubule Lumen Tubule Lumen Tubule Lumen
C 220.69 ± 3.13 61.29 ± 3.97 323.48 ± 10.63 82.98 ± 4.39 486.79 ± 9.21 188.5 ± 7.26
T 189.50 ± 2.67 47.47 ± 4.48 313.95 ± 16.58 100.97 ± 8.76 516.97 ± 11.29 216.45 ± 8.18
p < 0.001 p < 0.05 p < 0.05 p > 0.05 p < 0.05 p < 0.05
Mean diameter was estimated from 3 round-shaped seminiferous tubules of 3 testis sections from 5 rats for each group
breast milk. At 40 dpp, FT4 concentration in treated 
rats was similar to the control group, which indica-
tes a return to euthyroid state; however, thyroxine 
levels in 60-day-old treated rats were diminished, 
suggestive of lower thyroid activity. Similar results 
were obtained in rats after administration of exo-
genous T3 during the first five days post  partum 
to achieve hyperthyroidism [12]. This treatment 
produced the expected immediate suppression of 
plasma T4 and TSH, with recovery toward normal 
values beginning within days of discontinuing the T3 
regimen. Plasma T3 values were markedly elevated 
during the period in which T3 was administered, 
however, subsequently decreased with deficits 
persisting into young adulthood (50 dpp) [12]. 
As suggested by the authors, the future reactivity 
Figure 5. Testis sections in control (a-a1) and postnatal thyroxine treated (b-b1) 20-day-old rats. Bv: Blood vessel, It: 
Interstitial tissue, L: Lumen, S: Sertoli cell, Sct I: Spermatocyte I, Sg: Spermatogonium, St: Seminiferous tubule, arrows 
indicate closed seminiferous tubules. Total magnification: a-b: × 400, a1-b1: × 1000
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Figure 6. Testis sections in control (c and e-e1) and postnatal thyroxine treated (d and f-f1) 40- and 60-day-old rats. Lg: 
Leydig cell, Sg: Spermatogonium, SctI: Spermatocyte I, eStd: Elongated spermatide, rStd: Round spermatide. Total ma-
gnification: c-d: ×1000, control and treated animals 40 dpp, e-f: × 400, control and treated animals 60 dpp, e1-f1: ×1000, 
control and treated animals 60 dpp
dc
fe
f1e1 
to TSH seems to be determined during a critical 
period in which regulation of the pituitary-thyroid 
axis function is programmed by circulating thyroid 
hormones. Moreover, regulation of deiodinases’ 
activities cannot be excluded [12].
According to the results of other authors [9, 13, 14, 
15], hyperthyroidism induced by injection of thyroid 
hormones (T3: 50 µg/kg BW, 80 µg/kg BW, 100 µg/kg 
BW and T4: 50 µg/100 g BW, respectively) was asso-
ciated with a significant body mass loss which could 
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result from growth retardation resulting from imbal-
ance of thyroid hormones and growth hormone. The 
reduction of body weight observed in treated rats can 
also result from an increase in circulating adiponectin 
[16, 17]. Adiponectin increases insulin sensitivity by 
increasing fat oxidation resulting in a reduced body 
mass index [17] or a decrease in food intake of rats at 
weaning [15]. We did not observe any inflammation of 
the mammary glands in the mothers, or any behavior 
that could prevent pups from breastfeeding. The lower 
weight observed in treated rats could be caused by 
a potential decrease in lactation by affected mammary 
glands of hyperthyroid mothers, which has been re-
ported by Palermo et al. [18]. However, lactation was 
not measured in our study. 
In rat, Sertoli cell proliferation ceases by the age of 
20 days [19–21]. The onset of spermatogenesis occurs 
around 5 days of age and mature spermatozoa are 
released into lumen of seminiferous tubuli at the age 
of 50 days [22]. Fetal type Leydig cells disappear soon 
after birth, during the first 2 weeks, and are replaced 
by adult type Leydig cells [23]. Immature adult Leydig 
cells are present at 21–28 dpp and have 40% of the 
testosterone secretory capacity of the mature adult 
Leydig cells which appear at 28–56 dpp [24]. In our 
study, testes weights, plasma FT4 and testosterone le-
vels and testicular histomorphometry were performed 
at the age of 20 (pre-pubertal age), 40 (mid-pubertal 
age) and 60 days (post-pubertal age). 
Testes weight was reduced in our 20-day-old 
treated rats. A similar reduction was reported for 
Sprague Dawley rats which received daily injections of 
T3 (50 µg/Kg BW) for 21 days [9]. The average testes 
weights were not affected in T3 treated rats at days 
5 and 7, however, were significantly smaller than in 
controls at days 9, 12, 16 and 21 [9]. This decrease can 
be explained by a reduction of the total seminiferous 
tubules’ length per testis, due to early termination of 
Sertoli cells’ proliferation under hyperthyroid condi-
tions [25]. Sertoli cells play a key role in the initiation 
and maintenance of spermatogenesis [26] and are the 
first cell type known to differentiate within the fetal 
gonad [27, 28]. After birth, the immature Sertoli cells 
continue to proliferate until the beginning of puberty. 
At 15–20th day after birth in rats, the cells stop dividing 
and start differentiating into their non-proliferative 
adult form [17, 18]. Sertoli cells provide growth 
factors and nutrients for developing germ cells. The 
effects of T3 on Sertoli cells’ development are mainly 
exerted via TRa1 receptors [29, 30]. High neonatal 
triiodothyronine levels induce a reduction of Sertoli 
cells’ proliferation rate, in vivo, in rats [9, 25] and 
boars [31] and in vitro [32]. The effect on germ cells’ 
proliferation seems to depend on the duration of the 
treatment since short T3 administration was found 
to increase gonocyte differentiation, spermatogonia 
number, cell degeneration and proliferation at 6 dpp, 
T3 transient administration increased spermatogonial 
development to adult values precociously (16 dpp) 
without affecting degeneration or proliferation, while 
continuous T3 administration increased cell degen-
eration and proliferation, but cell number was not 
affected [8]. Otherwise, mild hyperthyroidism induced 
in dams did not seem to affect Sertoli cell proliferation 
and differentiation in the offspring, rather a transient 
delay in the progression of spermatogenesis, at the 
time when plasma T4 levels were significantly elevated 
for the first time (15 dpp), was observed [33]. 
In addition to the negative effect on the pro-
gression of spermatogenesis and differentiation of 
Sertoli cells, as indicated by the reduced diameters 
of seminiferous tubules at 20 and 40 days as well as 
delayed tubule lumen formation, decreased levels of 
testosterone obtained in this study indicate a role of 
thyroid hormones for Leydig cell functions. More-
over, hyperthyroidism-associated alterations in the 
sex steroid hormones’ metabolism, spermatogenesis 
and fertility, especially by affecting sperm motility, 
have been reported [34]. The presence of thyroid hor-
mones’ receptors TRa1 and TRa2 was demonstrated 
in immature and mature adult-type Leydig cells by 
Northern blot analysis [35] as well as using RT-PCR 
and immunohistochemistry [36]. According to Teerds 
et al. [37], thyroid hormones had a direct or indirect 
effect on the initiation of adult Leydig cells’ formation 
in 12- and 16-day-old rats. These authors showed that 
the proliferative activity and the percentage of the 
Leydig cells in the T3-treated animals compared to 
the controls were increased at the ages of 12 and 16 
days. At 16 dpp, in the hyperthyroid animals, precur-
sor cells were rapidly differentiating into adult-type 
Leydig cells and a significant reduction of plasma 
testosterone level was observed between controls and 
treated animals [37]. Their observations at the age 
of 16 dpp are important since we observed a signifi-
cant diminution in plasma testosterone levels in our 
20- and 40-day-old rats. Taken together, these results 
show that changes in neonatal-prepubertal thyroid 
hormone levels, directly or indirectly, influence the 
onset of the development of the adult-type Leydig 
cell population in the immature rat testis. While T3 
induces acceleration of Sertoli cells’ maturation [38, 
39], testosterone and estradiol act with FSH to stim-
ulate the Sertoli cells’ activity and spermatogenesis 
[40, 41]. Estradiol and FSH act to prevent germ cells’ 
apoptosis, stimulate spermatogonia differentiation 
and increase testosterone levels, while estradiol alone 
induces opposite effects [41, 42]. Synergic action 
113Thyroxine delays postnatal spermatogenesis
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2013
10.5603/FHC.2013.0017
www.fhc.viamedica.pl
of testosterone and FSH lead to maintain meiotic 
germ cells, and androgens are essential for the com-
pletion of meiosis [40, 43]. Decreased testosterone 
levels were probably associated with the slowdown 
of spermatogenesis observed in our study. 
In order to induce hyperthyroidism in animals, 
mainly T3 has been used by other researchers [9, 
12–14, 25, 37]. The daily T3 injection seems to cause 
a much more severe form of hyperthyroidism and 
lead to the acceleration of Sertoli cell and Leydig cell 
development as well as spermatogenesis [9, 14, 25, 37] 
while oral treatment of dams appears to be responsi-
ble for a transient delay of Leydig cell development 
and spermatogenesis in the offspring.
To our knowledge, there is only one previous stu-
dy, which results are in agreement with ours, in which 
hyperthyroidism was induced by orally administered 
T4 in dams [33]. Differences between the results 
obtained with T3 and T4 can be due to 1) the fact 
that circulating T4 is present at higher levels and has 
a longer half-life than the active form T3 [44] and 2) 
the testis bioavailability of T3 which is determined by 
hormone transport across membranes and T3 inacti-
vation by enzymatic deiodination [45, 46]. 
In conclusion, administration of 20 µg/100g BW 
thyroxine to lactating mothers resulted in a decrease 
of body and testis mass, plasma testosterone and al-
tered testicular histomorphometry in pups. In regard 
to other studies, the observed effects seem to depend 
on the dose, administration route and duration of T4 
treatment. Our results should be taken into account 
when assessing the risks of thyroxine treatment during 
lactation.
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